UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults

Vaccine, 2016-01, Vol.34 (3), p.341-349

2016

Volltextzugriff (PDF)

Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort

Clinical infectious diseases, 2013-05, Vol.56 (9), p.1248-1254

2013

Volltextzugriff (PDF)

Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters

The Journal of clinical investigation, 2018-09, Vol.128 (9), p.3853-3865

2018

Volltextzugriff (PDF)

Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak

Clinical infectious diseases, 2012-06, Vol.54 (12), p.1730-1735

2012

Volltextzugriff (PDF)

In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants

AIDS (London), 2014-06, Vol.28 (10), p.1421-1430

2014

Volltextzugriff (PDF)

Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age

The Pediatric infectious disease journal, 2010-03, Vol.29 (3), p.209-215

2010

Volltextzugriff (PDF)

Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial

Clinical infectious diseases, 2019-03, Vol.68 (7), p.1213-1222

2019

Volltextzugriff (PDF)

Functional Immune Cell Differences Associated With Low Vaccine Responses in Infants

The Journal of infectious diseases, 2016-06, Vol.213 (12), p.2014-2019

2016

Volltextzugriff (PDF)

Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand

Vaccine, 2017-01, Vol.35 (1), p.177-183

2017

Volltextzugriff (PDF)

Differential T- and B-Cell Responses to Pertussis in Acellular Vaccine-Primed versus Whole-Cell Vaccine-Primed Children 2 Years after Preschool Acellular Booster Vaccination

Clinical and Vaccine Immunology, 2013-09, Vol.20 (9), p.1388-1395

2013

Volltextzugriff (PDF)

Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy

Journal of Immunology Research, 2020, Vol.2020, p.8202067-11

2020

Volltextzugriff (PDF)

Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses

Vaccine, 2015-09, Vol.33 (39), p.5027-5030

2015

Volltextzugriff (PDF)

Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine

Vaccine, 2012-01, Vol.30 (3), p.544-551

2012

Volltextzugriff (PDF)

Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years

The Journal of infection, 2016-07, Vol.73 (1), p.38-44

2016

Volltextzugriff (PDF)

Epidemiology of pertussis

The Pediatric infectious disease journal, 2005-05, Vol.24 (5 Suppl), p.S10-S18

2005

Volltextzugriff (PDF)

Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection

Vaccine, 2012-11, Vol.30 (48), p.6897-6902

2012

Volltextzugriff (PDF)

Neonatal Vaccination with an Acellular Pertussis Vaccine Accelerates the Acquisition of Pertussis Antibodies in Infants

The Journal of pediatrics, 2008-05, Vol.152 (5), p.655-660.e1

2008

Volltextzugriff (PDF)

Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: Comparison of three different vaccines and effect of a booster dose

Vaccine, 2013-04, Vol.31 (15), p.1981-1986

2013

Volltextzugriff (PDF)

Restricted antibody response to Bordetella pertussis filamentous hemagglutinin induced by whole-cell and acellular pertussis vaccines

Infectious diseases (London, England), 2016-02, Vol.48 (2), p.127-132

2016

Volltextzugriff (PDF)

Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007

Clinical and Vaccine Immunology, 2014-02, Vol.21 (2), p.165-173

2014

Volltextzugriff (PDF)

Underestimating the Safety Benefits of a New Vaccine: The Impact of Acellular Pertussis Vaccine Versus Whole-Cell Pertussis Vaccine on Health Services Utilization

American journal of epidemiology, 2012-12, Vol.176 (11), p.1035-1042

2012

Volltextzugriff (PDF)

Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1–9 years old in Catalonia and Navarra (Spain)

European journal of clinical microbiology & infectious diseases, 2016-12, Vol.35 (12), p.2059-2067

2016

Volltextzugriff (PDF)

Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study

Vaccine, 2012-05, Vol.30 (23), p.3360-3368

2012

Volltextzugriff (PDF)

Polymorphism of IL-10 gene promoter region: association with T cell proliferative responses after acellular pertussis vaccination in adults

Immunogenetics (New York), 2016-10, Vol.68 (9), p.733-741

2016

Volltextzugriff (PDF)

Risk factors for developing apnea after immunization in the neonatal intensive care unit

Pediatrics (Evanston), 2008-03, Vol.121 (3), p.463-469

2008

Volltextzugriff (PDF)

1 – 25 von 409

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(375)
Mit Volltextzugriff
(304)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(405)
Female
(395)
Science & Technology
(364)
Life Sciences & Biomedicine
(363)
Diphtheria-Tetanus-Acellular Pertussis Vaccines - Administration & Dosage
(303)
Immunology
(220)
Infant
(216)
Vaccines
(199)
Infectious Diseases
(178)
Whooping Cough - Prevention & Control
(164)
Adolescent
(147)
Immunization
(145)
Child
(137)
Biological And Medical Sciences
(135)
Diphtheria-Tetanus-Acellular Pertussis Vaccines - Immunology
(127)
Tetanus
(125)
Child, Preschool
(123)
Whooping Cough
(123)
Pediatrics
(120)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults

Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort

Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters

Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak

In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants

Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age

Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial

Functional Immune Cell Differences Associated With Low Vaccine Responses in Infants

Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand

Differential T- and B-Cell Responses to Pertussis in Acellular Vaccine-Primed versus Whole-Cell Vaccine-Primed Children 2 Years after Preschool Acellular Booster Vaccination

Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy

Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses

Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine

Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years

Epidemiology of pertussis

Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection

Neonatal Vaccination with an Acellular Pertussis Vaccine Accelerates the Acquisition of Pertussis Antibodies in Infants

Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: Comparison of three different vaccines and effect of a booster dose

Restricted antibody response to Bordetella pertussis filamentous hemagglutinin induced by whole-cell and acellular pertussis vaccines

Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007

Underestimating the Safety Benefits of a New Vaccine: The Impact of Acellular Pertussis Vaccine Versus Whole-Cell Pertussis Vaccine on Health Services Utilization

Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1–9 years old in Catalonia and Navarra (Spain)

Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study

Polymorphism of IL-10 gene promoter region: association with T cell proliferative responses after acellular pertussis vaccination in adults

Risk factors for developing apnea after immunization in the neonatal intensive care unit

Aktive Filter

Suchergebnisse filtern